insights_auto
Why is EDIT down 13,82%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,87 US$
arrow_downward
-13,82%(-0,30) 1D
1,91 US$
arrow_upward
+2,14% (+0,040)bedtimeAfter hours
Closed: 16 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,10 US$
High
2,12 US$
Low
1,86 US$
Mkt. cap
288,62 მლნ.
Avg. vol.
2,44 მლნ.
Volume
2,11 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
2,10 US$
High
2,12 US$
Low
1,86 US$
Mkt. cap
288,62 მლნ.
Avg. vol.
2,44 მლნ.
Volume
2,11 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
Stocktwits
·
1 საათის წინ
S&P 500, Dow, Nasdaq End Lower As Investors Hold Back Ahead Of Nvidia Earnings, Anthropic IPO This Week — NVDA, TSLA, ANT In Focus
ChartMill
·
5 საათის წინ
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
BigGo Finance
·
11 საათის წინ
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Traders Union
·
1 საათის წინ
Airline shares post double-digit gains while S&P 500 falls, Phil Rosen notes
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc